<DOC>
	<DOCNO>NCT01475214</DOCNO>
	<brief_summary>With age , men woman develop mild progressive metabolic acidosis . This occur result decline renal function ingestion acid-producing diet . There extensive evidence severe metabolic acidosis cause bone muscle loss , impact chronic , mild acidosis bone muscle old individual establish . In recent study , administration single dose bicarbonate daily 3 month significantly reduce urinary excretion N-telopeptide ( NTX ) , marker bone resorption urinary nitrogen , marker muscle waste improved muscle performance woman men . These data support potential role bicarbonate mean reduce musculoskeletal decline lead extensive morbidity mortality elderly . Before proceed long-term bicarbonate intervention study , however , important identify dose bicarbonate likely optimal characterize subject benefit . This double blind , placebo control , dose-finding study evaluate effect placebo two dos bicarbonate urinary NTX nitrogen excretion low extremity performance 3 month period 138 men 138 woman , age 60 old . Changes urinary excretion NTX nitrogen select measure low extremity performance compare across three group . The safety tolerability intervention also evaluate . This investigation provide need information appropriate dose regimen men woman study population enrol future bicarbonate intervention trial assess long-term effect simple , low cost intervention important clinical outcome include rate loss bone muscle mass , fall , fracture .</brief_summary>
	<brief_title>Musculoskeletal Effects Bicarbonate</brief_title>
	<detailed_description>This dose-finding study evaluate effect placebo two dos bicarbonate urinary NTX nitrogen excretion low extremity performance three month period . The low dose similar dose show recent trial effective . This study double blind , randomize , placebo-controlled , parallel-group trial 138 healthy men 138 woman , age 60 old , take potassium bicarbonate dose 1.0 1.5 mmol/kg body weight placebo daily three month . Changes urinary excretion NTX nitrogen measure low extremity performance compare across three group . The safety tolerability intervention also evaluate . This investigation provide need information appropriate dosing regimen study population enrol future bicarbonate intervention trial assess long-term effect simple , low cost intervention important clinical outcome include rate loss bone muscle mass , fall , fracture .</detailed_description>
	<mesh_term>Osteoporosis</mesh_term>
	<criteria>men woman age 60 old community dwell woman 1 yr since last menses Medications : 1 . Oral glucocorticoid &gt; 10 day last 3 month Cortef ( hydrocortisone ) Prednisone 2 . Parenteral glucocorticoid • Decadron ( dexamethasone ) 3 . Osteoporosis medication last 6 month Forteo ( teriparatide ) Calcimar , Miacalcin ( calcitonin ) Evista ( raloxifene ) 4 . Osteoporosis medication last 2 year Fosamax ( alendronate ) Didronel ( etidronate ) Aredia ( pamidronate ) Actonel ( risedronate ) Reclast ( zoledronate ) 5 . Tamoxifen last 6 month 6 . Calcium/Parathyroid Rocaltrol ( calcitriol ) Zemplar ( paricalcitol ) Drisdol , Ergocalciferol 7 . Diuretics currently hydrocholorothiazide ( HCTZ ) Diuril ( chlorothiazide ) Thalitone ( chlorthalidone ) Zaroxolyn ( metolazone ) Dyazide Maxide Moduretic Lasix ( forosamine ) Dyrenium ( triamterene ) Midamor 8 . Testosterone estrogen last 6 month ( vaginal estrogen okay ) 9 . Angiotensin convert enzyme ( ACE ) inhibitor currently Benazepril ( Lotensin ) Captopril ( Capoten ) Enalapril ( Vasotec ) Fosinopril ( Monopril ) Lisinopril ( Prinivil , Zestril ) Moexipril ( Univasc ) Perindopril ( Aceon ) Quinapril ( Accupril ) Ramipril ( Altace ) Trandolapril ( Mavik ) 10 . Angiotensin II receptor blocker currently Candesartan ( Atacand ) Eprosartan ( Teveten ) Irbesartan ( Avapro ) Losartan ( Cozaar ) Olmesartan ( Benicar ) Telmisartan ( Micardis ) Valsartan ( Diovan ) OvertheCounter Drugs currently 1 . Antacids antacid contains calcium carbonate , aluminum hydroxide , magnesium hydroxide , calcium acetate select example include TUMS Mylanta Maalox Titralac Rolaids Sodium bicarbonate ( bake soda ) Note : magaldrate Riopan® allow 2 . Potassium supplement 3 . Salt substitute Conditions/Diseases 1. renal disease include kidney stone past 5 year glomerular filtration rate ( GFR ) &lt; 60 ml/min/1.73 m2 2. hyperkalemia ( serum potassium &gt; 5.3 meq/L ; normal range 3.55.3 meq/L ) 3. elevate serum bicarbonate ( serum bicarbonate &gt; 29 mmol/L ; normal range 2229 mmol/L ) 4. cirrhosis 5. gastroesophageal reflux disease ( GERD ) require treatment alkalicontaining antacid ( TUMS , Mylanta , Maalox , Titralac , Rolaids , sodium bicarbonate ) 6. hyperparathyroidism 7. untreated thyroid disease 8. significant immune disorder rheumatoid arthritis 9. current unstable heart disease 10. active malignancy cancer therapy last year 11. fasting spot urine calcium/creatinine &gt; 0.38 mmol/mmol 1 wk calcium supplement 12. congestive heart failure , arrhythmia ( surgically treat arrhythmias acceptable ) , myocardial infarction last 12 month 13. serum calcium outside normal range 8.310.2 mg/dl 14. uncontrolled diabetes mellitus ( fast blood sugar &gt; 130 ) 15. alcohol use exceed 2 drinks/day 16. peptic ulcer esophageal stricture 17. weight &lt; 45 &gt; 113.5 kg ( &lt; 99 &gt; 249.7 lb ) 18. abnormality screen lab , discretion study physician ( PI )</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>potassium bicarbonate</keyword>
	<keyword>urinary N-telopeptide</keyword>
	<keyword>urinary nitrogen</keyword>
	<keyword>net acid excretion</keyword>
</DOC>